Literature DB >> 24930866

Nodular lymphoid hyperplasia of the colon in a vervet monkey (Cholorocebous aethiops).

M H Hablolvarid1.   

Abstract

BACKGROUND: Diffuse nodular lymphoid hyperplasia (DNLH) of gastrointestinal tract is regarded as a very rare disease in the adult population. It is characterized by presence of diffuse detectable small polypoid masses distributed in the small intestine, colon, or both.
METHODS: A 6-year-old male in captivity suddenly died, due to myocardial infarction. During routine necropsy procedure, incidentally, numerous tan, sessile polyps, up to 0.2 cm were noticed in all segments of the colon.
RESULTS: Histopathological and immunohistochemical examination revealed polypoid masses as nodular lymphoid hyperplasia (NLH), comparable with DNLH of the colon in human.
CONCLUSIONS: In this article, the author has tried to introduce some immunosuppresive (e.g., simian retrovirus type D (SRV), simian immunodeficiency virus (SIV)) and opportunistic viruses (e.g., lymphocryptovirus, γ-herpesvirus, adenovirus), as well as, primary and opportunistic bacteria (e.g., Yersinia psedotuberculosis, and Helicobacter spp.) that may trigger benign reactive process, lymphoid hyperplasia, in non-human primates (NHPs) in captivity.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  African green monkey; histopathology; immunohistochemistry

Mesh:

Year:  2014        PMID: 24930866     DOI: 10.1111/jmp.12133

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  1 in total

1.  ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.

Authors:  Deniz Cagdas; Pınar Gur Cetinkaya; Betül Karaatmaca; Saliha Esenboga; Cagman Tan; Togay Yılmaz; Ersin Gümüş; Safa Barış; Barış Kuşkonmaz; Tuba Turul Ozgur; Pawan Bali; Ines Santisteban; Diclehan Orhan; Aysel Yüce; Duygu Cetinkaya; Kaan Boztug; Michael Hershfield; Ozden Sanal; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2018-05-09       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.